Hypoxia makes EZH2 inhibitor not easy—advances of crosstalk between HIF and EZH2 is a research paper published in Life Metabolism (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA107469
NCI NIH HHS
Grant: R01 CA125577
National Institutes of Health
Grant: 5R01CA107469-07
Role of EZH2 in Breast Cancer Progression
National Institutes of Health
Grant: 5R01CA125577-04
Role of CCN6 (WISP3) in the progression and metastasis of breast cancer
Fields of Study
Keywords